Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Pays Idaho Tech $3.5M to Settle PCR Patent Suit, Pens Cross-Licensing Pact

NEW YORK (GenomeWeb News) — Cepheid has paid Idaho Technology $3.5 million and penned a cross-licensing agreement to settle a patent-infringement suit, Cepheid said today.
 
Terms of the settlement call for the companies to pay license fees and enable them to “continue to make and sell their respective lines for products.
 
Idaho Technology sued Cephied in 2005 for allegedly infringing three patents that cover "rapid polymerase chain reaction methods and instrumentation, use of SYBR Green I in PCR reactions, and certain methods of analysis of real-time PCR data,” Cepheid said.
 
Cepheid said the settlement “resolves all claims” made by Idaho Tech and its licensor, University of Utah Research Foundation, and resulted in a dismissal of the case.
 
Idaho Technology, based in Salt Lake City, makes instruments for pathogen detection, reagents, and thermocyclers.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.